Abstract
Over the last 10 years, diagnosis and treatment of primary liver cancer has progressed dramatically. Better understanding of hepatocellular carcinoma and advances in imaging techniques have enabled the detection of small asymptomatic tumors in cirrhosis [1]. With regard to treatment, several options are now available: partial resection, transplantation, chemoembolization, ethanol injection, radiotherapy, and hormone therapy [2–6]. Nevertheless, even if the advances in surgical techniques and perioperative management have contributed to the improvement of short- and long-term results of partial resection, the resecability rate remains low and the recurrence rate after resection is high [2,3]. Recurrences that are de-novo tumor developed with cirrhosis or real recurrence of the removed tumor [7] are the major causes of death after hepatectomy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Okuda K. 1992. Hepatocellular carcinoma: Recent progress. Hepatology 15:948–963.
Liver Cancer Study Group of Japan. 1990. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287.
Bismuth H, Houssin D, Ornowski J, Merrigi F. 1986. Liver resections in cirrhotic patients: A Western experience. World J Surg 10:311–317.
Bismuth H, Morino M, Sherlock D, et al. 1992. Primary treatment of hepatocellular carcinoma by arterial chemoembolisation. Am J Surg 163:387–394.
Shiina S, Tagawa K, Unuma T, et al. 1991. Percutaneous ethanol injection therapy for hepatocellular carcinoma: A histopathologic study. Cancer 68:1524–1530.
Ohto M, Ebara M, Yoshikawa M, Okuda K. 1990. Radiation therapy and percutaneous ethanol injection for liver neoplasms: Analysis of 79 cases. Radiology 177:156–158.
Hsu HC, Chiou TJ, Chen JY, et al. 1991. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology 13:923–928.
Koneru B, Cassavilla A, Bowman J, et al. 1988. Liver transplantation for malignant tumors. Gastroenterol Clin North Am 17:177–181.
Olthoff KM, Millis JM, Rosove MH, et al. 1990. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–1268.
Ismail T, Angrisani L, Gunson FK, et al. 1990. Primary hepatic malignancy: The role of liver transplantation. Br J Surg 77:983–987.
O’Grady JG, Poison RJ, Rolles K, et al. 1988. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207:373–379
Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. 1989. The role of liver transplantation in hepatobiliary malignancy. A retrostective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 209:88–97.
Yokoyama I, Todo S, Iwatsuki S, Starzl TE. 1990. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–193.
Penn I. 1991. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110:726–735.
Haug CE, Jenkins RL, Rohrer RJ, et al. 1992. Liver transplantation for primary hepatic cancer. Transplantation 53:376–382.
Starzl TE, Iwatsuki S, Shaw BW, et al. 1986. Treatment of fibrolamellar carcinoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 162: 145–148.
Ringe B, Pichylmayr R, Wittekind C, Tusch G. 1991. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 15:270–285.
Iwatsuki S, Starzl TE, Sheahan DG, et al. 1991. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221–229.
Bismuth H, Chiche L, Adam R, Castaing D. 1993. Surgical treatment of hepatocellular carcinoma in cirrhosis: Liver resection or transplantation? Transplant Proc, in press.
Nakashima T, Okuda K, Kojiro M. 1983. Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in 10 years. Cancer 51:863–877.
Okamoto E, Tanaka N, Yakamana N, Toyosaka A. 1984. Results of surgical treatments of primary hepatocellular carcinoma: Some aspects to improve long-term survival. World J Surg 8:360–366.
Zhou XD, Tang Zu, Yu Yq, et al. 1989. Hepatocellular carcinoma: Some aspects to improve long-term survival. J Surg Oncol 41:256–262.
Starzl TE, Todo S, Tsakis A, et al. 1989. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 210:374–385.
Yuki K, Hirohashi S, Sakamoto M, et al. 1990. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66:2174–2179.
Yokoyama I, Sheahan DG, Carr B, et al. 1991. Clinicopathologic factors affecting patient survival and tumor reccurence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 23:2194–2196.
Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. 1991. Accelerated growth rates of recurrent hepatocellular carcinoma after transplantation. Cancer 68:2095–2100.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Bismuth, H., Chiche, L. (1994). Liver transplantation as an option for primary malignancy. In: Sugarbaker, P.H. (eds) Hepatobiliary Cancer. Cancer Treatment and Research, vol 69. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2604-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2604-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6115-2
Online ISBN: 978-1-4615-2604-9
eBook Packages: Springer Book Archive